A detailed history of Allworth Financial LP transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 37 shares of MEDP stock, worth $13,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 17 117.65%
Holding current value
$13,122
Previous $6,000 150.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$372.0 - $424.34 $7,440 - $8,486
20 Added 117.65%
37 $15,000
Q3 2023

Oct 31, 2023

BUY
$233.98 - $281.67 $2,105 - $2,535
9 Added 112.5%
17 $4,000
Q4 2022

Jan 13, 2023

BUY
$153.06 - $226.57 $765 - $1,132
5 Added 166.67%
8 $0
Q2 2022

Jul 13, 2022

SELL
$130.2 - $168.03 $390 - $504
-3 Reduced 50.0%
3 $0
Q1 2022

Apr 22, 2022

SELL
$138.87 - $214.31 $4,721 - $7,286
-34 Reduced 85.0%
6 $1,000
Q4 2021

Jan 21, 2022

BUY
$182.74 - $227.9 $7,309 - $9,116
40 New
40 $9,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $11B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.